Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 18/07/2026 +04			After hours 04:00:00
76.65 ^USD	-1.71%		76.44	-0.27%

07-16	Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating	MT
07-16	Abbott raises 2026 profit forecast on heart device strength	RE

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							24
	ABBOTT LABORATORIES							24
	MEDTRONIC PLC							25
	CENCORA, INC.							12
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							11
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							15
	STERIS PLC							7
	SARTORIUS STEDIM BIOTECH							14
	TERUMO CORPORATION							13
	ZIMMER BIOMET HOLDINGS, INC.							20
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	ALIGN TECHNOLOGY, INC.							15
	BAXTER INTERNATIONAL INC.							11
	INSULET CORPORATION							23
	GLOBUS MEDICAL, INC.							12
	DEMANT A/S							20
	REPLIGEN CORPORATION							20
	Average							17
	Weighted average by Cap.							19